Company Jaguar Health Inc Nasdaq
Equities
US47010C3007
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Health
98.2
%
| 12 | 98.2 % | 10 | 98.2 % | -18.34% |
Animal Health
1.8
%
| 0 | 1.8 % | 0 | 1.8 % | -19.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 12 | 100.0 % | 10 | 100.0 % | -18.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 | |
Jonathan Wolin
CMP | Compliance Officer | 62 | 18-10-31 |
Chief Tech/Sci/R&D Officer | 62 | 21-04-30 | |
Peter C. Hodge
IRC | Investor Relations Contact | - | - |
Karen Brunke
PRN | Corporate Officer/Principal | 72 | 21-09-08 |
Ian Wendt
PRN | Corporate Officer/Principal | - | - |
David Sesin
PRN | Corporate Officer/Principal | - | - |
Steven King
PRN | Corporate Officer/Principal | 66 | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
Jonathan Siegel
BRD | Director/Board Member | 50 | 18-03-28 |
Director/Board Member | 67 | 22-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 9 | 0 | 0 | 98.22 % |
Stock B | 1 | 276,216,260 | 271,297,541 ( 98.22 %) | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |